Gene · 57674
Papers1,364
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,364
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNF213 isoform 2 restricts Zika virus through antiviral signaling and viral protein degradation. | iScience | 2026 | 42305619 | PubTator, text mining | PubMed |
| RNF213 deficiency in human iPSC-derived vascular organoids captures key feature of moyamoya disease vasculopathy. | Microvasc Res | 2026 | 42289232 | PubTator, text mining | PubMed |
| RNF213 Variants Associated With Periventricular Anastomosis Regression After Revascularization in Moyamoya Disease. | CNS Neurosci Ther | 2026 | 42286852 | PubTator, text mining | PubMed |
| Extracranial vascular association of moyamoya disease: a systematic review and machine learning analysis. | Neurol Sci | 2026 | 42265449 | PubTator, text mining | PubMed |
| Intracranial Arterial Stenosis beyond Atherosclerosis: Insights from RNF213. | J Atheroscler Thromb | 2026 | 42236180 | PubTator, text mining | PubMed |
| The host ubiquitination system dynamically regulates the inflammatory response of macrophages to bacteria. | Front Immunol | 2026 | 42199436 | PubTator, text mining | PubMed |
| An Overview of Genetics of Moyamoya: Beyond RNF213 Gene. | Int J Mol Sci | 2026 | 42196405 | PubTator, text mining | PubMed |
| Experimental Approach to Moyamoya Angiopathy: Insights into Vascular Cell Crosstalk. | Cells | 2026 | 42193873 | PubTator, text mining | PubMed |
| Aplastic or twig-like middle cerebral artery with the RNF213 variant: illustrative cases. | J Neurosurg Case Lessons | 2026 | 42184445 | PubTator, text mining | PubMed |
| Intraoperative Iliac Artery Dissection and Postoperative Cerebral Infarction in a Kidney Transplant Recipient With an RNF213 p.R4810K Variant: A Case Report. | Transplant Proc | 2026 | 42144299 | PubTator, text mining | PubMed |
| Association between posterior cerebral artery involvement and arterial wall enhancement in moyamoya disease: a cross-sectional study with vessel wall imaging. | Neuroradiology | 2026 | 42138735 | PubTator, text mining | PubMed |
| Non-Atherosclerotic and Genetic Intracranial Stenoses: Diagnostic Challenges and Emerging Genetic Insights. | J Neuroendovasc Ther | 2026 | 42116864 | PubTator, text mining | PubMed |
| Long-term outcomes in the pre-moyamoya stage of RNF213-related vasculopathy presenting with ischaemic stroke or transient ischaemic attack: insights from the NCVC Genome Registry. | Lancet Reg Health West Pac | 2026 | 42079473 | PubTator, text mining | PubMed |
| Characterization of T-Cell Ubiquitination in Melanoma and Development of a Risk Signature Using Single-Cell and Bulk RNA-Seq. | Immunology | 2026 | 42012139 | PubTator, text mining | PubMed |
| Current Insights into the Molecular Mechanisms of Intracranial Atherosclerosis and Their Therapeutic Implications. | Int J Mol Sci | 2026 | 41977444 | PubTator, text mining | PubMed |
| De novo twig-like middle cerebral artery after suspected M1 dissection in early childhood with coexisting KRAS-mutated brain arteriovenous malformation: illustrative case. | J Neurosurg Case Lessons | 2026 | 41941829 | PubTator, text mining | PubMed |
| Grange-Like Phenotype Associated With an RNF213 Pathogenic Variant: Expanding the Vasculopathy Spectrum. | Am J Med Genet A | 2026 | 41937270 | PubTator, text mining | PubMed |
| Cerebral small vessel disease imaging markers and disease severity in moyamoya disease: Insights from magnetic resonance imaging analysis. | Eur J Radiol | 2026 | 41916136 | PubTator, text mining | PubMed |
| RNF213-TRAF2 interaction enhances inflammatory responses via NF-κB activation in moyamoya disease. | Int Immunol | 2026 | 41891799 | PubTator, text mining | PubMed |
| AKT1 phosphorylates PRMT7 to promote GLUD1 methylation and gastric cancer progression. | Cell Death Dis | 2026 | 41876450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57674/papers?page=2